People with dementia are diagnosed an average of 3.5 years after symptoms are first noticed, or even longer (4.1 years) for those with early-onset dementia, finds a new study led by UCL researchers.
Jul 27, 2025
0
105
An analysis of studies incorporating data from almost 30 million people has highlighted the role that air pollution—including that coming from car exhaust emissions—plays in increased risk of dementia.
Jul 24, 2025
0
81
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in ...
Jul 22, 2025
0
32
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other antidiabetic drugs, according ...
Jul 22, 2025
0
0
New research from Karolinska Institutet demonstrates a link between inflammatory bowel disease and faster cognitive decline among dementia patients. The study, which is published in the journal Gut, indicates a need for personalized ...
Jul 22, 2025
0
63
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is), ...
Jul 22, 2025
0
0
Matthew Leming, Ph.D., and Hyungsoon Im, Ph.D. of the Center for Systems Biology at Massachusetts General Hospital, are the co-corresponding authors of a paper published in Alzheimer's & Dementia, "Differential dementia detection ...
Jul 21, 2025
0
0
In a study published in Alzheimer's & Dementia, a team led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences—collaborating with Dr. Jed A. Barash from the Massachusetts ...
Jul 21, 2025
0
0
Scientists know that many proteins and pathways are involved in the development and progression of neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease and frontotemporal dementia (FTD), and that ...
Jul 21, 2025
0
30
The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease. Sifting through roughly 250 million plasma measurements, ...
